Status:
COMPLETED
A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients
Lead Sponsor:
Excelsior
Conditions:
Trientine Treatment for Wilson's Disease
Eligibility:
All Genders
3-75 years
Brief Summary
This is a retrospective study to assess the clinical efficacy and safety of trientine in Wilson's disease patients
Detailed Description
In this retrospective study, the investigators will collect and analyze data from reviewing medical history files of larger and long-term follow-up cohorts with Wilson's disease in Taiwan to assess th...
Eligibility Criteria
Inclusion
- Diagnosis of Wilson's disease.
- Male or female patients, aged 3 years to 75 years
Exclusion
- Patients with comorbidity which is not related to Wilson's disease.
Key Trial Info
Start Date :
January 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03299829
Start Date
January 10 2018
End Date
December 30 2019
Last Update
August 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Linkou
Taoyuan, Taiwan, 333